These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28339802)

  • 21. Urine biomarkers of chronic kidney damage and renal functional decline in childhood-onset systemic lupus erythematosus.
    Brunner HI; Gulati G; Klein-Gitelman MS; Rouster-Stevens KA; Tucker L; Ardoin SP; Onel KB; Mainville R; Turnier J; Aydin POA; Witte D; Huang B; Bennett MR; Devarajan P
    Pediatr Nephrol; 2019 Jan; 34(1):117-128. PubMed ID: 30159624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Collagen Type III and VI Remodeling Biomarkers Are Associated with Kidney Fibrosis in Lupus Nephritis.
    Genovese F; Akhgar A; Lim SS; Farris AB; Battle M; Cobb J; Sinibaldi D; Karsdal MA; White WI
    Kidney360; 2021 Sep; 2(9):1473-1481. PubMed ID: 35373114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary vitamin D-binding protein, a novel biomarker for lupus nephritis, predicts the development of proteinuric flare.
    Go DJ; Lee JY; Kang MJ; Lee EY; Lee EB; Yi EC; Song YW
    Lupus; 2018 Sep; 27(10):1600-1615. PubMed ID: 29958502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association Between Urinary Epidermal Growth Factor and Renal Prognosis in Lupus Nephritis.
    Mejia-Vilet JM; Shapiro JP; Zhang XL; Cruz C; Zimmerman G; Méndez-Pérez RA; Cano-Verduzco ML; Parikh SV; Nagaraja HN; Morales-Buenrostro LE; Rovin BH
    Arthritis Rheumatol; 2021 Feb; 73(2):244-254. PubMed ID: 32892508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
    Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG
    Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial Dysfunction in Systemic Lupus Erythematosus with a Focus on Lupus Nephritis.
    Halfon M; Tankeu AT; Ribi C
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary TNF-like weak inducer of apoptosis (TWEAK) as a biomarker of lupus nephritis.
    Salem MN; Taha HA; Abd El-Fattah El-Feqi M; Eesa NN; Mohamed RA
    Z Rheumatol; 2018 Feb; 77(1):71-77. PubMed ID: 27619369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary levels of sirtuin-1 associated with disease activity in lupus nephritis.
    Olivares D; Perez-Hernandez J; Forner MJ; Perez-Soriano C; Tormos MC; Saez GT; Chaves FJ; Redon J; Cortes R
    Clin Sci (Lond); 2018 Mar; 132(5):569-579. PubMed ID: 29440621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrative analysis of COL6A3 in lupus nephritis: insights from single-cell transcriptomics and proteomics.
    Mou L; Zhang F; Liu X; Lu Y; Yue M; Lai Y; Pu Z; Huang X; Wang M
    Front Immunol; 2024; 15():1309447. PubMed ID: 38855105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological aspects of biopsy-proven lupus nephritis in Bahraini patients with systemic lupus erythematosus.
    Farid EM; Hassan AB; Abalkhail AA; El-Agroudy AE; Arrayed SA; Al-Ghareeb SM
    Saudi J Kidney Dis Transpl; 2013 Nov; 24(6):1271-9. PubMed ID: 24231503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood ceramides as novel markers for renal impairment in systemic lupus erythematosus.
    Patyna S; Büttner S; Eckes T; Obermüller N; Bartel C; Braner A; Trautmann S; Thomas D; Geiger H; Pfeilschifter J; Koch A
    Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106348. PubMed ID: 31301404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages.
    Zhang T; Li H; Vanarsa K; Gidley G; Mok CC; Petri M; Saxena R; Mohan C
    Front Immunol; 2020; 11():671. PubMed ID: 32351512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary markers differentially associate with kidney inflammatory activity and chronicity measures in patients with lupus nephritis.
    Akhgar A; Sinibaldi D; Zeng L; Farris AB; Cobb J; Battle M; Chain D; Cann JA; Illei GG; Lim SS; White WI
    Lupus Sci Med; 2023 Jan; 10(1):. PubMed ID: 36717181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cleaved Form of Osteopontin in Urine as a Clinical Marker of Lupus Nephritis.
    Kitagori K; Yoshifuji H; Oku T; Sasaki C; Miyata H; Mori KP; Nakajima T; Ohmura K; Kawabata D; Yukawa N; Imura Y; Murakami K; Nakashima R; Usui T; Fujii T; Sakai K; Yanagita M; Hirayama Y; Mimori T
    PLoS One; 2016; 11(12):e0167141. PubMed ID: 27992535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients.
    He D; Liu M; Liu B
    Tohoku J Exp Med; 2018 Apr; 244(4):263-270. PubMed ID: 29576585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic and Diagnostic Values of Novel Serum and Urine Biomarkers in Lupus Nephritis: A Systematic Review.
    Radin M; Miraglia P; Barinotti A; Fenoglio R; Roccatello D; Sciascia S
    Am J Nephrol; 2021; 52(7):559-571. PubMed ID: 34515043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary Peptides as Potential Non-Invasive Biomarkers for Lupus Nephritis: Results of the Peptidu-LUP Study.
    Tailliar M; Schanstra JP; Dierckx T; Breuil B; Hanouna G; Charles N; Bascands JL; Dussol B; Vazi A; Chiche L; Siwy J; Faguer S; Daniel L; Daugas E; Jourde-Chiche N; On Behalf Of The Groupe Coopératif Sur le Lupus Rénal Gclr
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33920017
    [No Abstract]   [Full Text] [Related]  

  • 38. Human neutrophil peptide 1-3, a component of the neutrophil extracellular trap, as a potential biomarker of lupus nephritis.
    Cheng FJ; Zhou XJ; Zhao YF; Zhao MH; Zhang H
    Int J Rheum Dis; 2015 Jun; 18(5):533-40. PubMed ID: 25196784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. U-KIM-1 as a predictor of treatment response in lupus nephritis.
    Nozaki Y; Shiga T; Ashida C; Tomita D; Itami T; Kishimoto K; Kinoshita K; Matsumura I
    Lupus; 2023 Jan; 32(1):54-62. PubMed ID: 36305170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urine S100 proteins as potential biomarkers of lupus nephritis activity.
    Turnier JL; Fall N; Thornton S; Witte D; Bennett MR; Appenzeller S; Klein-Gitelman MS; Grom AA; Brunner HI
    Arthritis Res Ther; 2017 Oct; 19(1):242. PubMed ID: 29065913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.